Sana Biotechnology (SANA)

• Market cap: $1.05B
• 1 day: 0.99%
• 5 days: -16.02%
• 1 month: -0.73%
• 3 months: 37.71%
• 6 months: 140.59%
• Year to date: 147.88%
• 1 year: 31.94%
• 5 years: -88.35%
• 10 years: -88.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Employees: 194